Literature DB >> 10716499

Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.

M T Huisman, J W Smit, A H Schinkel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10716499     DOI： 10.1097/00002030-200002180-00005

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  31 in total

1.  The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV-1-infected individuals.

Authors:  C H Koks; K M Crommentuyn; R M Hoetelmans; D M Burger; P P Koopmans; R A Mathôt; J W Mulder; P L Meenhorst; J H Beijnen
Journal:  Br J Clin Pharmacol       Date:  2001-06       Impact factor: 4.335

Review 2.  The role of therapeutic drug monitoring in treatment of HIV infection.

Authors:  D J Back; S H Khoo; S E Gibbons; C Merry
Journal:  Br J Clin Pharmacol       Date:  2001-04       Impact factor: 4.335

3.  Expression of P-170 glycoprotein sensitizes lymphoblastoid CEM cells to mitochondria-mediated apoptosis.

Authors:  P Matarrese; U Testa; R Cauda; S Vella; L Gambardella; W Malorni
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 4.  Drug interactions between antiretroviral drugs and comedicated agents.

Authors:  Monique M R de Maat; G Corine Ekhart; Alwin D R Huitema; Cornelis H W Koks; Jan W Mulder; Jos H Beijnen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Drug Interactions Among the Antiretrovirals.

Authors:  Ian R. McNicholl
Journal:  Curr Infect Dis Rep       Date:  2004-04       Impact factor: 3.725

Review 6.  The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions.

Authors:  Lawrence M DuBuske
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

7.  Interaction potential of etravirine with drug transporters assessed in vitro.

Authors:  Nadine Cécile Luise Zembruski; Walter Emil Haefeli; Johanna Weiss
Journal:  Antimicrob Agents Chemother       Date:  2010-12-28       Impact factor: 5.191

8.  High variability of indinavir and nelfinavir pharmacokinetics in HIV-infected patients with a sustained virological response on highly active antiretroviral therapy.

Authors:  Cécile Goujard; Mayeule Legrand; Xavière Panhard; Bertrand Diquet; Xavier Duval; Gilles Peytavin; Isabelle Vincent; Christine Katlama; Catherine Leport; Bénédicte Bonnet; Dominique Salmon-Céron; France Mentré; Anne-Marie Taburet
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

9.  Binary and ternary combinations of anti-HIV protease inhibitors: effect on gene expression and functional activity of CYP3A4 and efflux transporters.

Authors:  Deep Kwatra; Aswani Dutt Vadlapudi; Ramya Krishna Vadlapatla; Varun Khurana; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Metabol Drug Interact       Date:  2014

Review 10.  PharmGKB summary: cyclosporine and tacrolimus pathways.

Authors:  Julia M Barbarino; Christine E Staatz; Raman Venkataramanan; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2013-10       Impact factor: 2.089
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.